## APTV: Aptiv PLC - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -2.3% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($72.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Aptiv PLC (APTV) Stock Sinks As Market Gains: What You Should Know**
- Source: sharewise.com | 20251222T235000 | Neutral | Relevance: 100%
- Aptiv PLC (APTV) experienced a stock decline of 1.39% while the broader market gained, with the S&P 500 up 0.64%. Despite recent stock growth of 5.61% over the past month, it lagged the Auto-Tires-Trucks sector's 14.81% gain. Analysts project positive earnings and revenue growth for Aptiv's upcoming reports, holding a Zacks Rank #3 (Hold) and trading at a discount compared to its industry's Forward P/E ratio.

**2. Aptiv PLC (APTV) Stock Sinks As Market Gains: What You Should Know**
- Source: Yahoo Finance Singapore | 20251222T230910 | Neutral | Relevance: 96%
- Aptiv PLC (APTV) experienced a -1.39% decline in its stock value, closing at $77.20, despite general market gains by the S&P 500 and Dow. Analysts forecast a 2.29% increase in EPS to $1.79 and a 2.58% rise in quarterly revenue to $5.03 billion for Aptiv. The company currently holds a Zacks Rank of #3 (Hold) and is trading at a Forward P/E ratio of 10.13, which is a discount compared to its industry average of 16.83.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Wells Fargo | $99 | $100 | -1% |
| 2025-12-08 | Morgan Stanley | $84 | $60 | +40% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Wells Fargo | main | Overweight |
| 2025-12-08 | Morgan Stanley | up | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.30M) |
| Sells | 9 ($6.42M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-1.0%)
- Blackrock Inc.: 8.0% (+2.2%)
- Massachusetts Financ: 4.3% (-15.7%)
- State Street Corpora: 4.1% (-1.1%)
- Barrow, Hanley Mewhi: 3.2% (-6.9%)

### Key Risks

1. Insider selling cluster: $6.4M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Insider selling cluster ($6.4M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.6B |
| Beta | 1.52 |
| 52W Range | $47.19 - $88.80 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 9.1 |
| Current P/E | 9.9 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.4% to -2.3% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.3pp (needs >4.0% for momentum thesis). Underperforming sector by 3.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). RSI neutral at 44. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.34% (CS: 29) | Weak |
| RSI_14 | 44.3 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.957x | Below |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $76.34
- **Stop Loss:** $72.48 (5.1% risk)
- **Target:** $80.20 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 233
- **Position Value:** $17,787.22
- **Portfolio %:** 17.79%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $1.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.83 | $2.17 | +18.8% |
| 2025Q2 | $1.83 | $2.12 | +15.8% |
| 2025Q1 | $1.53 | $1.69 | +10.1% |
| 2024Q4 | $1.65 | $1.75 | +6.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*